Iyú D et al. |
The role of prostanoid receptors in mediating the effects of PGE3 on human platelet function. |
2012 |
Thromb. Haemost. |
pmid:22318645
|
Wal F et al. |
PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin. |
1985 |
Thromb. Haemost. |
pmid:3992525
|
van Giezen JJ et al. |
Fibrinolytic activity in blood is distributed over a cellular and the plasma fraction which can be modulated separately. |
1994 |
Thromb. Haemost. |
pmid:7740459
|
Taylor RR et al. |
Time dependence of whole blood aggregation in response to platelet activating factor (PAF). |
1988 |
Thromb. Haemost. |
pmid:3388292
|
Powling MJ and Hardisty RM |
Potentiation by adrenaline of Ca2+ influx and mobilization in stimulated human platelets: dissociation from thromboxane generation and aggregation. |
1988 |
Thromb. Haemost. |
pmid:3388294
|
Hornby EJ and Perry CR |
1-O-hexadecyl-2-acetyl-sn-3-glycerophosphorylcholine (PAF): some effects on the aggregation of human platelets by thrombin or collagen. |
1983 |
Thromb. Haemost. |
pmid:6636035
|
Castro-Faria-Neto HC et al. |
Platelet mobilization induced by PAF and its role in the thrombocytosis triggered by adrenaline in rats. |
1989 |
Thromb. Haemost. |
pmid:2617459
|
Montrucchio G et al. |
Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood. |
2003 |
Thromb. Haemost. |
pmid:14597983
|
Hermán F et al. |
In vivo antiaggregatory action of platelet-activating factor in beagle dogs: role for prostacyclin. |
1991 |
Thromb. Haemost. |
pmid:2048053
|
Chou KJ et al. |
Platelet hyperreactivity in hemodialysis patients with frequently occluded vascular access. |
2004 |
Thromb. Haemost. |
pmid:15351860
|
Pipili E |
Platelet membrane potential: simultaneous measurement of diSC3(5) fluorescence and optical density. |
1985 |
Thromb. Haemost. |
pmid:2418525
|
Ou MC et al. |
Potential etiologic role of PAF in two major septic complications; disseminated intravascular coagulation and multiple organ failure. |
1994 |
Thromb. Res. |
pmid:8191415
|
Le Blanc K et al. |
Impaired platelet binding of fibrinogen due to a lower number of GPIIB/IIIA receptors in polycythemia vera. |
1998 |
Thromb. Res. |
pmid:9772010
|
Eche N et al. |
Platelet aggregating and procoagulant activities of cultured human breast cancer cells (FAM). |
1986 |
Thromb. Res. |
pmid:3726808
|
Kakishita E et al. |
Inhibitory effect of vitamin E (alpha-tocopherol) on spontaneous platelet aggregation in whole blood. |
1990 |
Thromb. Res. |
pmid:2082481
|
Powling MJ and Hardisty RM |
Differential effects of 12-O-tetradecanoylphorbol 13-acetate on platelet responses to various agonists in the presence and absence of extracellular Ca2+. |
1986 |
Thromb. Res. |
pmid:3787566
|
Chang GT et al. |
Purification and characterization of a new anticoagulant protein, PP27, from placenta. |
2005 |
Thromb. Res. |
pmid:16122555
|
Siffert W et al. |
Inhibition of platelet aggregation by amiloride. |
1986 |
Thromb. Res. |
pmid:3787567
|
Alam I et al. |
Human and rabbit platelets form platelet-activating factor in response to calcium ionophore. |
1983 |
Thromb. Res. |
pmid:6407140
|
Simon MF et al. |
Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets. |
1987 |
Thromb. Res. |
pmid:3576518
|
Bush LR and Smith SG |
Antagonism of U46619-induced aggregation of human and canine platelets by four TXA2 receptor antagonists. |
1986 |
Thromb. Res. |
pmid:2948294
|
Belch JJ et al. |
Whole blood white cell aggregation: a novel technique. |
1987 |
Thromb. Res. |
pmid:2448894
|
Ostermann G et al. |
Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor. |
1983 |
Thromb. Res. |
pmid:6408754
|
Liu X et al. |
Ginkgolide B inhibits platelet release by blocking Syk and p38 MAPK phosphorylation in thrombin-stimulated platelets. |
2014 |
Thromb. Res. |
pmid:25223809
|
Nguyên P et al. |
Mechanisms of the platelet aggregation induced by activated neutrophils and inhibitory effect of specific PAF receptor antagonists. |
1995 |
Thromb. Res. |
pmid:7778064
|
Vargaftig BB et al. |
Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets. |
1982 |
Thromb. Res. |
pmid:7164036
|
Namm DH and High JA |
Thrombin-induced formation of a polar lipid material within platelets that possesses platelet-activating activity. |
1980 |
Thromb. Res. |
pmid:7209881
|
Hanss M and Dechavanne M |
48740 RP, an antagonist of PAF, does not affect human plasma fibrinolysis before and after venous occlusion. |
1988 |
Thromb. Res. |
pmid:3126559
|
Okamoto M et al. |
Platelet activating factor (PAF) involvement in endotoxin-induced thrombocytopenia in rabbits: studies with FR-900452, a specific inhibitor of PAF. |
1986 |
Thromb. Res. |
pmid:3754990
|
Sturk A et al. |
Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway. |
1985 |
Thromb. Res. |
pmid:2934863
|
Namm DH et al. |
Species specificity of the platelet responses to 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine. |
1982 |
Thromb. Res. |
pmid:7071810
|
Juhan-Vague I et al. |
Possible participation of adenosine 5'-diphosphate, arachidonic acid and paf-acether in the platelet pro-aggregating effect of uncontrolled insulin-dependent diabetic erythrocytes in vitro. |
1985 |
Thromb. Res. |
pmid:3923649
|
Violi F et al. |
Inhibition of cyclooxygenase-independent platelet aggregation by sodium salicylate. |
1989 |
Thromb. Res. |
pmid:2506658
|
Shukla SD et al. |
Hypersensitivity of diabetic human platelets to platelet activating factor. |
1992 |
Thromb. Res. |
pmid:1329254
|
Tsien WH et al. |
Variable responses of human platelets to synthetic platelet activating factor and their modification by epinephrine. |
1982 |
Thromb. Res. |
pmid:7164038
|
Kurose I et al. |
Involvement of superoxide anion and platelet-activating factor in increased tissue-type plasminogen activator during rat gastric microvascular damages. |
1991 |
Thromb. Res. |
pmid:1650966
|
Valone FH |
Inhibition of platelet-activating factor binding to human platelets by calcium channel blockers. |
1987 |
Thromb. Res. |
pmid:3590086
|
Tokumura A et al. |
Platelet aggregation induced by ether-linked phospholipids. 2. Mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists. |
1987 |
Thromb. Res. |
pmid:3590110
|
Brown JE and Thuy LP |
The binding of bovine platelet aggregating factor to human platelets. |
1981 Apr 1-15 |
Thromb. Res. |
pmid:7292446
|
Kloprogge E et al. |
Properties of PAF-acether-induced platelet aggregation and secretion. Studies in gel-filtered human platelets. |
1983 |
Thromb. Res. |
pmid:6222507
|
Ishii H et al. |
Thiolprotease inhibitor, EST, can inhibit thrombin-induced platelet activation. |
1990 |
Thromb. Res. |
pmid:2382255
|
Wade PJ et al. |
Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human platelets. |
1986 |
Thromb. Res. |
pmid:3961730
|
Karlsson H et al. |
Heparin ameliorates pulmonary hypertension induced by platelet-activating factor in pigs. |
1998 |
Thromb. Res. |
pmid:9694244
|
Hofmann B et al. |
Proaggregatory and inhibitory effects of 2-O-ethyl analogues of platelet-activating factor (PAF) on human and rabbit platelets. |
1988 |
Thromb. Res. |
pmid:3381200
|
Cox CP and Wood KL |
Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam. |
1987 |
Thromb. Res. |
pmid:3629553
|
Catalán RE et al. |
Dissociation between secretion and protein phosphorylation in agonist-stimulated platelets; action of PCA-4230, a new antithrombotic drug. |
1994 |
Thromb. Res. |
pmid:7974386
|
Ostermann G et al. |
Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor. |
1987 |
Thromb. Res. |
pmid:3629555
|
Nishizawa EE and Della-Coletta AA |
The formation of a thrombin-like material (TLM) following stimulation of leukocytes. |
1984 |
Thromb. Res. |
pmid:6484896
|
Heinrich J and Zimmermann RE |
Compound 48/80 is a potent inhibitor of human platelet aggregation antagonizing the calmodulin-dependent platelet reaction in vitro. |
1984 |
Thromb. Res. |
pmid:6523451
|
Glusa E et al. |
Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation. |
1989 |
Thromb. Res. |
pmid:2528843
|
Stahl GL et al. |
Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shock. |
1989 |
Thromb. Res. |
pmid:2718150
|
Valone FH |
Platelet-activating factor binding and metabolism during human platelet aggregation. |
1988 |
Thromb. Res. |
pmid:3400077
|
Hwang SB et al. |
Effects of nonsteroid antiinflammatory drugs on the specific binding of platelet activating factor to membrane preparations of rabbit platelets. |
1984 |
Thromb. Res. |
pmid:6429890
|
Sloan IG and Firkin BG |
Impaired fibrinolysis in patients with thrombotic or haemostatic defects. |
1989 |
Thromb. Res. |
pmid:2814943
|
Skeaff CM and Holub BJ |
The effect of fish oil consumption on platelet aggregation responses in washed human platelet suspensions. |
1988 |
Thromb. Res. |
pmid:3187952
|
Griffin KJ and Levy JV |
The thieno-triazolodiazepine WEB 2086 inhibits platelet aggregation and ATP release from porcine platelets induced by platelet activating factor (PAF). |
1988 |
Thromb. Res. |
pmid:3187959
|
Ostermann G et al. |
Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets. |
1984 |
Thromb. Res. |
pmid:6710440
|
Lalau Keraly C et al. |
Inhibition by ticlopidine of Paf-acether-induced in vitro aggregation of rabbit and human platelets. |
1984 |
Thromb. Res. |
pmid:6740569
|
Beaumont DO et al. |
Measuring platelet function with platelet shape change, an early event in aggregation. |
1989 |
Thromb. Res. |
pmid:2646752
|
Janero DR et al. |
Specific binding of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) to the intact canine platelet. |
1988 |
Thromb. Res. |
pmid:3413730
|
Seth P et al. |
Effect of platelet activating factor antagonists in different models of thrombosis. |
1994 |
Thromb. Res. |
pmid:7900097
|
Bernat A and Herbert JM |
Effect of various drugs on adriamycin-enhanced venous thrombosis in the rat: importance of PAF. |
1994 |
Thromb. Res. |
pmid:8073411
|
Klöcking HP et al. |
Release of tissue-type plasminogen activator by platelet-activating factor. |
1985 |
Thromb. Res. |
pmid:4040278
|
Pletscher A et al. |
LDL induced shape change reaction of platelets is not due to PAF. |
1989 |
Thromb. Res. |
pmid:2609294
|
Cox CP |
Effects of CV-3988, an antagonist of platelet-activating factor (PAF), on washed rabbit platelets. |
1986 |
Thromb. Res. |
pmid:2421432
|
Croft KD and Beilin LJ |
Platelet and neutrophil function and eicosanoid release in a subject with abetalipoproteinaemia. |
1993 |
Thromb. Res. |
pmid:8385810
|
Vrzheshch PV et al. |
Cell response kinetics: the phenomenon of supercooperativity in aggregation of human platelets. |
1992 |
Thromb. Res. |
pmid:1523610
|
Teng CM et al. |
Antiplatelet actions of some coumarin compounds isolated from plant sources. |
1992 |
Thromb. Res. |
pmid:1523611
|
Valone FH and Johnson B |
Decay of the activating signal after platelet stimulation with 1-0-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine: changes in calcium permeability. |
1985 |
Thromb. Res. |
pmid:4082115
|
Joseph R et al. |
Platelet-activating factor and red blood cells. |
1989 |
Thromb. Res. |
pmid:2734734
|
Ostermann G et al. |
The role of lipoproteins in the degradation of platelet-activating factor. |
1986 |
Thromb. Res. |
pmid:3798402
|
Battistini B et al. |
Endothelin-1 does not affect human platelet aggregation in whole blood and platelet rich plasma. |
1990 |
Thromb. Res. |
pmid:2278035
|
Ostermann G et al. |
Inhibition of PAF-induced human platelet responses by newly synthesized ether phospholipids. |
1991 |
Thromb. Res. |
pmid:2028445
|
Joseph R et al. |
Endothelin-1 and human platelet activity. |
1991 |
Thromb. Res. |
pmid:2028454
|
Tencé M et al. |
Ether-phospholipid composition in neutrophils and platelets. |
1985 |
Thromb. Res. |
pmid:4024039
|
Hadváry P and Baumgartner HR |
Activation of human and rabbit blood platelets by synthetic structural analogs of platelet activating factor. |
1983 |
Thromb. Res. |
pmid:6868019
|
Leoncini G et al. |
Hyperactivity and increased hydrogen peroxide formation in platelets of NIDDM patients. |
1997 |
Thromb. Res. |
pmid:9175236
|
Tan EL and Snyder F |
Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by capillary endothelial cells isolated from rat epididymal adipose tissue. |
1985 |
Thromb. Res. |
pmid:4024051
|
Ding YA et al. |
Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound. |
1995 |
Thromb. Res. |
pmid:7740521
|
Garcia JG et al. |
Effect of platelet activating factor on leukocyte-endothelial cell interactions. |
1988 |
Thromb. Res. |
pmid:2842887
|
Bussolino F et al. |
Intravascular release of platelet activating factor in children with sepsis. |
1987 |
Thromb. Res. |
pmid:3441909
|
Suzuki K et al. |
The influence of 2-mercaptoethanol on von Willebrand factor and bovine platelet aggregating factor. |
1980 Feb 1-15 |
Thromb. Res. |
pmid:6966083
|
Küster LJ and Frölich JC |
PAF-induced platelet aggregation and TXB2 formation. |
1989 |
Thromb. Res. |
pmid:2922704
|
Ostermann G et al. |
Stimulation and desensitization of human and rabbit platelets by 1-O-hexadecyl-2-O-methyl-rac-glycero-3-phosphocholine and analogues. |
1986 |
Thromb. Res. |
pmid:3764811
|
Ishii H et al. |
A platelet aggregating substance contained in xanthine oxidase preparation from cow's milk. |
1982 |
Thromb. Res. |
pmid:6897588
|
Ostermann G et al. |
The degradation of platelet-activating factor in serum and its discriminative value in atherosclerotic patients. |
1988 |
Thromb. Res. |
pmid:3232123
|
Avdonin PV et al. |
Blocking of the receptor-stimulated calcium entry into human platelets by verapamil and nicardipine. |
1988 |
Thromb. Res. |
pmid:3232128
|
Neiman J et al. |
Platelet responses to platelet-activating factor are inhibited in alcoholics undergoing alcohol withdrawal. |
1989 |
Thromb. Res. |
pmid:2617478
|
Pfliegler G et al. |
Sodium fluoride induced activation of phospholipase C in intact human platelets does not depend on ADP, PAF or arachidonate products. |
1993 |
Thromb. Res. |
pmid:8503122
|
Altman R et al. |
Why single daily dose of aspirin may not prevent platelet aggregation. |
1988 |
Thromb. Res. |
pmid:3140408
|
Avdonin PV et al. |
Evidence for the receptor-operated calcium channels in human platelet plasma membrane. |
1987 |
Thromb. Res. |
pmid:2438805
|
Lukaszyk A et al. |
Does acute experimental pancreatitis affect blood platelet function? |
1989 |
Thromb. Res. |
pmid:2524119
|
Lecompte T et al. |
Aequorin-detected calcium changes in stimulated thrombasthenic platelets. Aggregation-dependent calcium movement in response to ADP. |
1990 |
Thromb. Res. |
pmid:2117306
|
McGowan EB and Detwiler TC |
Characterization of the thrombin-induced desensitization of platelet activation by thrombin. |
1983 |
Thromb. Res. |
pmid:6356458
|
Mabilat-Pragnon C et al. |
Urokinase localization and activity in isolated eosinophils. |
1997 |
Thromb. Res. |
pmid:9526961
|
Kinlough-Rathbone RL et al. |
Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents. |
1999 |
Thromb. Res. |
pmid:10527409
|
Csáki C et al. |
Role of platelet-activating factor in the development of endothelial dysfunction in hemorrhagic hypotension and retransfusion. |
1992 |
Thromb. Res. |
pmid:1412179
|
May JA et al. |
Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man. |
1997 |
Thromb. Res. |
pmid:9361371
|
Patterson WR et al. |
Aggregation of killer whale platelets. |
1993 |
Thromb. Res. |
pmid:8327987
|
Lian EC et al. |
Purification and some properties of a protein obtained from normal human plasma which inhibits the platelet aggregation induced by thrombotic thrombocytopenic purpura plasma. |
1984 |
Thromb. Res. |
pmid:6420930
|